Synthetic Biology
AI in Molecular Biology: Revolutionizing the Future of Biotech
09-08-2025 / Rob Ford Field Application Scientist, GenScript
AI in Molecular Biology: Revolutionizing the Future of Biotech
Learn More
Antibody
High-Titer Lentivirus Solutions in 5 Days: Break Production Barriers for CGT
09-04-2025 / Chuanxin Liu, PhD, Head of Viral Vector R&D, GenScript Biotech Corporation
Watch this webinar to gain insights into lentivirus innovations driving breakthroughs in in vivo CAR-T and gene delivery.
Learn More Protein
Protein
Enhance productivity and purity in next-generation bispecific antibody manufacturing
07-14-2025 / Dr. Heng Tai Liew, Senior Protein Scientist, GenScript Biotech
In this webinar, we will introduce GenScript’s TurboCHOTM technology, which addresses these challenges through an integrated and iterative workflow that optimizes cell lines, vectors, and media using Design of Experiments (DOE) to fine-tune chain ratios a
Learn More Protein
AI-based Antibody Therapeutics Developability Assessment and Its Engineering
02-27-2025 / Dr. Carter Hao, Senior Bioinformatics Scientist
In this webinar, we are excited to present our Immunoinformatics Comprehensive Service Platform, which leverages AI for the developability assessment of antibody therapeutics.
Learn More Antibody
Maximizing PK and ADA Evaluation Efficiency with Our Cutting-Edge Rabbit Antibody Development Technology
10-18-2024 / Dr. Hui Foon Tan, Sr. Global Product Manager - Antibody, GenScript Biotech
Discover how GenScript's cutting-edge rabbit anti-idiotypic antibody (Anti-ID Ab) development technology enhances pharmacokinetics (PK) and anti-drug antibody (ADA) assays.
Learn More Synthetic Biology
The Power of DNA Mutant Libraries: Accelerating Revolution in Research
09-04-2024 / Dr. Xing Gao Global Product Manager, Molecular Biology, GenScript
Discover an informative webinar focusing on the revolutionary impact of DNA mutant libraries in biomedical research and development.
Learn More Antibody
AI-based Antibody Therapeutics Developability Assessment and Its Engineering
06-21-2024 / Dr. Carter Hao
Monoclonal antibodies (mAbs) have become essential in treating a wide spectrum of diseases, with over 100 therapeutic antibody products now approved and commercially available.
Learn More